Next Article in Journal
Heat-Killed Enterococcus faecalis EF-2001 Ameliorates Atopic Dermatitis in a Murine Model
Next Article in Special Issue
Clinical Evaluation of Effects of Chronic Resveratrol Supplementation on Cerebrovascular Function, Cognition, Mood, Physical Function and General Well-Being in Postmenopausal Women—Rationale and Study Design
Previous Article in Journal
The Effects of Creatine Supplementation on Explosive Performance and Optimal Individual Postactivation Potentiation Time
Previous Article in Special Issue
Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals
Open AccessArticle

Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells

Institute of Anatomy, Ludwig-Maximilian-University Munich, Pettenkoferstrasse 11, Munich D-80336, Germany
Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran 141556453, Iran
Investigating Institute of Molecular Biological System Transfer, Tehran 1417863171, Iran
Department of Anatomy and Cell Biology, Biomedical Center, Ludwig-Maximilian-University Munich, Martinsried D-82152, Germany
Center for Gastrointestinal Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, TX 75246, USA
Author to whom correspondence should be addressed.
Nutrients 2016, 8(3), 145;
Received: 22 December 2015 / Revised: 5 February 2016 / Accepted: 18 February 2016 / Published: 5 March 2016
(This article belongs to the Special Issue Selected Papers from Resveratrol Regional Meeting 2015)
Sirt1 is a NAD+-dependent protein-modifying enzyme involved in regulating gene expression, DNA damage repair, metabolism and survival, as well as acts as an important subcellular target of resveratrol. The complex mechanisms underlying Sirt1 signaling during carcinogenesis remain controversial, as it can serve both as a tumor promoter and suppressor. Whether resveratrol-mediated chemopreventive effects are mediated via Sirt1 in CRC growth and metastasis remains unclear; which was the subject of this study. We found that resveratrol suppressed proliferation and invasion of two different human CRC cells in a dose-dependent manner, and interestingly, this was accompanied with a significant decrease in Ki-67 expression. By transient transfection of CRC cells with Sirt1-ASO, we demonstrated that the anti-tumor effects of resveratrol on cells was abolished, suggesting the essential role of this enzyme in the resveratrol signaling pathway. Moreover, resveratrol downregulated nuclear localization of NF-κB, NF-κB phosphorylation and its acetylation, causing attenuation of NF-κB-regulated gene products (MMP-9, CXCR4) involved in tumor-invasion and metastasis. Finally, Sirt1 was found to interact directly with NF-κB, and resveratrol did not suppress Sirt1-ASO-induced NF-κB phosphorylation, acetylation and NF-κB-regulated gene products. Overall, our results demonstrate that resveratrol can suppress tumorigenesis, at least in part by targeting Sirt1 and suppression of NF-κB activation. View Full-Text
Keywords: human colon cancer; Sirt1; NF-κB; alginate; resveratrol; carcinogenesis human colon cancer; Sirt1; NF-κB; alginate; resveratrol; carcinogenesis
Show Figures

Graphical abstract

MDPI and ACS Style

Buhrmann, C.; Shayan, P.; Popper, B.; Goel, A.; Shakibaei, M. Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells. Nutrients 2016, 8, 145.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop